ESAB is trading 5.5% down now at $86.77 as investors continue digesting the August 6 earnings report and lower 2026 EPS guidance.
- Second-quarter sales rose 12.9%, while full-year sales and EBITDA outlooks increased.
- Adjusted EPS was $1.33 versus a $1.43 consensus estimate; 2026 EPS guidance fell to $5.40–$5.50 because of Eddyfi financing and integration costs.
- The broader market is only modestly weaker, making the company-specific earnings reaction the primary catalyst. Trading activity and volume details were unavailable.